Latest filing published 26 Dec 2018 for OncoMed Pharmaceuticals Inc, €5,864.
Austin Gurney discloses dealings in OncoMed Pharmaceuticals Inc to SEC (Form 4). The record holds 36 filings, for trades running from 23 July 2013 to 24 December 2018.
Every open-market trade on record is a sale: 30 sales worth €1.5M. Besides market trades, the filings include 4 share grants. Since January 2018: no purchases and 4 sales on the market.
Most recently, on 26 December 2018, the filings show an open-market sale worth €5,864 in OncoMed Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 36 declarations